1. Screening of wild deer populations for exposure to SARS-CoV-2 in the United Kingdom, 2020-2021.
- Author
-
Holding M, Otter AD, Dowall S, Takumi K, Hicks B, Coleman T, Hemingway G, Royds M, Findlay-Wilson S, Curran-French M, Vipond R, Sprong H, and Hewson R
- Subjects
- Animals, Animals, Wild, Antibodies, Viral, COVID-19 Testing veterinary, Humans, SARS-CoV-2, Spike Glycoprotein, Coronavirus, COVID-19 epidemiology, COVID-19 veterinary, Deer
- Abstract
Following findings in Northern America of SARS-CoV-2 infections in white-tailed deer, there is concern of similar infections in European deer and their potential as reservoirs of SARS-CoV-2 including opportunities for the emergence of new variants. UK deer sera were collected in 2020-2021 from 6 species and a hybrid with 1748 tested using anti-spike and anti-nucleocapsid serology assays. No samples were positive on both assays nor by surrogate neutralization testing. There is no evidence that spill-over infections of SARS-CoV-2 occurred from the human population to UK deer or that SARS-CoV-2 has been circulating in UK deer (over the study period). Although it cannot be ruled out, study results indicate that spill-over infections followed by circulation of SARS-CoV-2 to the most common European deer species is small., (© 2022 Crown copyright. Transboundary and Emerging Diseases published by Wiley-VCH GmbH. This article is published with the permission of the Controller of HMSO and the Queen's Printer for Scotland.)
- Published
- 2022
- Full Text
- View/download PDF